LH Levels May Be Used as an Indicator for the Time of Antagonist Administration in GnRH Antagonist Protocols—A Proof-Of-Concept Study

Frontiers in Endocrinology- Switzerland

doi 10.3389/fendo.2019.00067

Full Text

Abstract

Available in

Date

Authors

Publisher

Frontiers Media SA

Related search

Oxidative Stress Markers in GnRH AgonistaAnd Antagonist Protocols in IVF

Journal of Medical Biochemistry
BiochemistryClinical Biochemistry
2017English

Pregnancy Rates in Frozen-Thawed Cycles After GnRH-agonist or Antagonist Protocols

Fertility and Sterility
GynecologyReproductive MedicineObstetrics
2016English

GnRH Antagonist Administration to Postpone a Weekend Intrauterine Insemination: A Large Cohort Study From a Public Center

Reproductive Biology and Endocrinology
GynecologyEndocrinologyReproductive MedicineDevelopmental BiologyObstetrics
2016English

GnRH Antagonist Treatment of Malignant Adrenocortical Tumors

Yearbook of Paediatric Endocrinology
2019English

Impact of Serum Progesterone Levels in GnRH Antagonist Assisted Reproduction Cycles on Pregnancy Outcomes: A Prospective Cohort Study

Open Journal of Obstetrics and Gynecology
2019English

Individualized Treatment From Theory to Practice: The Private Case of Adding LH During GnRH Antagonist-Based Stimulation Protocol

Clinical Medicine Insights: Reproductive Health
Reproductive Medicine
2014English

A Comparative Study Between GnRH Antagonist and Long Agonist Protocols in Patients With Polycystic Ovarian Syndrome (PCOS) Undergoing in Vitro Fertilization

Journal of Fertilization: In Vitro - IVF-Worldwide, Reproductive Medicine, Genetics & Stem Cell Biology
2014English

Can Readmission Rates Be Used as an Outcome Indicator?

BMJ
1990English

Relugolix: New 0ral Gonadotropin-Releasing Hormone (GnRH) Antagonist

Biomedical Journal of Scientific & Technical Research
2019Spanish

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy